TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
This study has been terminated.
(Amgen Administrative Decision - termination of LTFU)
First Posted: December 16, 2011
Last Update Posted: February 23, 2017
Information provided by (Responsible Party):